Adam Kittai

Dr. Adam Kittai is an Associate Professor, director of the CLL Program for the system, and director of the lymphoma program for Long Island, at the Perlmutter Cancer Center at New York University. Dr. Kittai is internationally recognized for the care and research of patients with non-Hodgkin lymphoma, with a specific focus on CLL and Richter transformation. He is a clinical investigator and challenges treatment paradigms; having developed and implemented many investigator-initiated trials and performing retrospective and population-based research. He has a passion to mentor future Hematologists/Oncologists and currently chairs the American Society of Hematology Malignant Careers in Hematology Advancement Mentorship program.